Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Your doctor may prescribe Revuforj tablets in multiple dosage strengths, and it ···【more】
Release date：2026-01-28Recommended：52
Revumenib is a menin inhibitor that blocks the interaction between wild-type lys···【more】
Release date：2026-01-28Recommended：55
Revuforj tablets are available in different dosage strengths, each corresponding···【more】
Release date：2026-01-28Recommended：63
Revuforj is typically indicated for the treatment of patients with specific type···【more】
Release date：2026-01-28Recommended：69
On June 24, 2025, Syndax Pharmaceuticals announced that the U.S. Food and Drug A···【more】
Release date：2026-01-28Recommended：63
Acute lymphoblastic leukemia (ALL) is a hematologic malignancy originating from ···【more】
Release date：2026-01-28Recommended：48
Recently, Syndax Pharmaceuticals announced additional positive data from the AUG···【more】
Release date：2026-01-28Recommended：49
Lorlatinib is a third-generation ALK/ROS1 tyrosine kinase inhibitor, primarily i···【more】
Release date：2026-01-27Recommended：46
Lorlatinib is a third-generation targeted therapy indicated for ALK-positive met···【more】
Release date：2026-01-26Recommended：37
Concurrent use of this medicine with any of the following medications is general···【more】
Release date：2026-01-26Recommended：63
While certain medications should not be used together at all, in other cases, it···【more】
Release date：2026-01-26Recommended：61
While exerting the intended therapeutic effects, a medication may also induce ce···【more】
Release date：2026-01-26Recommended：62
